Skip to content

Tulsi Consumption and Its Effects on Cognition, Stress and Anxiety

Consumption of Tulsi and Its Effects on Neurocognition, Stress and Anxiety: A Randomised Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03184909
Enrollment
30
Registered
2017-06-14
Start date
2017-12-14
Completion date
2018-03-31
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Change

Brief summary

Tulsi and its effects on facilitative cognitive enhancement through lowering levels of stress and anxiety. A randomised placebo-controlled clinical trial.

Detailed description

Ocimum Sanctum or Holy Basil, commonly called Tulsi is a traditional Indian herb. It is believed to bring about a facilitative enhancement of cognitive ability and lower stress levels in individuals. Stress and an inability to perform at a required level of cognition can induce anxiety. This study is looking at the effects of daily consuming Tulsi among a group of individuals who work in an environment that demands memory, attention and executive functioning.

Interventions

Active capsules containing leaves of organically prepared ocimum sanctum

DRUGPlacebo

Placebo capsules of look alike inert substance for control

Sponsors

Composite Interceptive Med Science
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Concealment of allocation and blinding of active versus placebo and blinded assessment

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects between the ages of 18 and 50 years, providing written informed consent.

Exclusion criteria

Subjects who meet the following criteria * Education level below 8th grade of schooling * Unable to read or understand English or having no working knowledge of English * Known history or neurological conditions that can affect cognition * Known history of drug abuse or potential for drug abuse, a regular consumer of alcohol or unwilling to withhold consumption of alcohol for the duration of the study. * A chronic smoker or consumer of other tobacco related products or is undergoing a rehabilitation program for alcohol and or tobacco consumption * Any history or psychiatric disorders - currently on treatment or treated in within the last 12 months * Any characteristic that makes the investigator uncomfortable to include the subject in the study.

Design outcomes

Primary

MeasureTime frameDescription
To assess a change in facilitative cognitive function from baseline in 6 weeks by comparing the results on cognitive tests measured by Cambridge Neuropsychological Test Automated Battery (Cantab®) between active and placebo group6 weeksThe Cambridge Neuropsychological Test Automated Battery (CANTAB) is a digital tool to measure the cognitive function.

Secondary

MeasureTime frameDescription
To measure change in cortisol level from saliva in 6 weeks6 weeksSalivary levels of cortisol correlates with work related stress levels. Our intention is to evaluate the effect of ocimum sanctum in lowering stress and measured as a change in the cortisol levels
To measure change in Generalized Anxiety Disorder 7-Item Scale in 6 weeks6 weeksIt is a self-reported questionnaire for screening and severity measuring of generalized anxiety disorder (GAD)

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026